These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1719060)

  • 41. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
    Chong AS; Scuderi P; Grimes WJ; Hersh EM
    J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Human natural killer activity in selected test systems and tissue compartments: natural killer cell modulation by biological response modifiers].
    Klappacher G
    Wien Klin Wochenschr; 1988 Nov; 100(22):743-6. PubMed ID: 3149079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level.
    Chikkala NF; Lewis I; Ulchaker J; Stanley J; Tubbs R; Finke JH
    Cancer Res; 1990 Feb; 50(4):1176-82. PubMed ID: 2297766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ; Krosnick JA; Rosenberg SA
    J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.
    Handa K; Suzuki R; Matsui H; Shimizu Y; Kumagai K
    J Immunol; 1983 Feb; 130(2):988-92. PubMed ID: 6294182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
    Brooks CG; Holscher M; Urdal D
    J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors.
    Iigo M; Sakurai M; Tamura T; Saijo N; Hoshi A
    Cancer Res; 1988 Jan; 48(2):260-4. PubMed ID: 2446744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
    Talmadge JE; Tribble HR; Pennington RW; Phillips H; Wiltrout RH
    Cancer Res; 1987 May; 47(10):2563-70. PubMed ID: 3105865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T; Sone S
    J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.
    Langermans JA; Van der Hulst ME; Nibbering PH; Hiemstra PS; Fransen L; Van Furth R
    J Immunol; 1992 Jan; 148(2):568-74. PubMed ID: 1729374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.
    Talmadge JE; Herberman RB; Chirigos MA; Maluish AE; Schneider MA; Adams JS; Philips H; Thurman GB; Varesio L; Long C
    J Immunol; 1985 Oct; 135(4):2483-91. PubMed ID: 2411797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural killer activity is present in rat lung lavage and inhibited by lidocaine.
    Renzi PM; Ginns LC
    Immunopharmacol Immunotoxicol; 1990; 12(3):389-415. PubMed ID: 2266229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Naloxone modulates NK-cell activity of human peripheral blood lymphocytes like an opioid agonist.
    Martin-Kleiner I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):179-97. PubMed ID: 7688780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
    Mandrup-Poulsen T; Bendtzen K; Dinarello CA; Nerup J
    J Immunol; 1987 Dec; 139(12):4077-82. PubMed ID: 3320203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low-doses of sequential-kinetic-activated interferon-γ enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study.
    Radice E; Miranda V; Bellone G
    Int Immunopharmacol; 2014 Mar; 19(1):66-73. PubMed ID: 24369312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restoring Natural Killer Cell Cytotoxicity After Hyperthermia Alone or Combined with Radiotherapy.
    Hietanen T; Kapanen M; Kellokumpu-Lehtinen PL
    Anticancer Res; 2016 Feb; 36(2):555-63. PubMed ID: 26851009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.
    Bandyopadhyay S; Miller DS; Matsumoto-Kobayashi M; Clark SC; Starr SE
    Clin Exp Immunol; 1987 Feb; 67(2):372-82. PubMed ID: 2440628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.